HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for hydrochlorothiazide; moexipril hydrochloride and what is the scope of patent protection?
Hydrochlorothiazide; moexipril hydrochloride
is the generic ingredient in two branded drugs marketed by Chartwell Rx, Glenmark Pharms, Heritage, Teva, and Ucb Inc, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.Summary for HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 5 |
| NDAs: | 5 |
| Clinical Trials: | 3 |
| DailyMed Link: | HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Teva Pharmaceuticals USA | Phase 1 |
| Paddock Laboratories, Inc. | Phase 1 |
See all HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
Paragraph IV (Patent) Challenges for HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| UNIRETIC | Tablets | hydrochlorothiazide; moexipril hydrochloride | 7.5mg/12.5mg, 15 mg/25 mg and 15 mg/12.5 mg | 020729 | 1 | 2004-01-15 |
US Patents and Regulatory Information for HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ucb Inc | UNIRETIC | hydrochlorothiazide; moexipril hydrochloride | TABLET;ORAL | 020729-001 | Jun 27, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ucb Inc | UNIRETIC | hydrochlorothiazide; moexipril hydrochloride | TABLET;ORAL | 020729-003 | Feb 14, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Heritage | MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; moexipril hydrochloride | TABLET;ORAL | 202150-001 | Mar 7, 2014 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chartwell Rx | MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; moexipril hydrochloride | TABLET;ORAL | 090096-001 | Sep 25, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ucb Inc | UNIRETIC | hydrochlorothiazide; moexipril hydrochloride | TABLET;ORAL | 020729-002 | Jun 27, 1997 | ⤷ Sign Up | ⤷ Sign Up |
| Ucb Inc | UNIRETIC | hydrochlorothiazide; moexipril hydrochloride | TABLET;ORAL | 020729-001 | Jun 27, 1997 | ⤷ Sign Up | ⤷ Sign Up |
| Ucb Inc | UNIRETIC | hydrochlorothiazide; moexipril hydrochloride | TABLET;ORAL | 020729-002 | Jun 27, 1997 | ⤷ Sign Up | ⤷ Sign Up |
| Ucb Inc | UNIRETIC | hydrochlorothiazide; moexipril hydrochloride | TABLET;ORAL | 020729-003 | Feb 14, 2002 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
